Explore insights on over 50M companies, 160M patents, and 550k clinical trials in one powerful platform. Turn data into opportunities and act with confidence.
Say goodbye to generic databases and incomplete intel, say hello to personalization, efficiency and accuracy you never thought possible.
Early-stage assets and breakthrough science carry enormous promise, but also unpredictable clinical, regulatory, and market risks that make accurate valuation difficult.
Innovation, M&A and CVC teams often pursue overlapping opportunities, but organizational silos and differing priorities can slow or derail critical decisions.
Emerging biotech and medtech companies often have sparse clinical results, making it hard to judge their true scientific and commercial viability.
Find critical company information 21x faster
Reduce the risk of missing a perfect fit by 97%
Companies from over 200 jurisdictions worldwide
Based on our customer satisfaction scores.
Our AI-powered scouting surfaces emerging biotech, medtech, and digital health companies worldwide, even those in early-stage growth so pharmaceutical innovation teams can spot promising technologies before competitors.
Tap into a database of over 160 million patents, and 550k clinical trial records worldwide, giving you instant visibility into study phases, outcomes, and competitive landscapes to evaluate potential partners with precision.
FounderNest centralizes intelligence so regional and functional teams share a single view of targets, avoiding duplicate outreach and enabling faster, unified decision-making on partnerships, licensing, or acquisitions.
“FounderNest has become an essential tool for us, sharpening our innovation edge and propelling Novo Nordisk towards the future of healthcare.”
FounderNest uses AI-driven search across the most comprehensive global datasets, including stealth startups, niche markets, and non-English sources to uncover opportunities before they appear in traditional industry databases.
Yes, FounderNest offers flexible API and platform integrations so your teams can access market intelligence directly within your existing workflows and collaboration systems.
Our database aggregates over 160 million patents and clinical trial records and continuously updates from verified global sources, including regulatory agencies, patent offices, and company disclosures.
We provide multi-region coverage and regulatory intelligence to assess risks in different markets, helping teams navigate local compliance, IP issues, and market entry challenges.
Unlike static databases, FounderNest applies AI to connect company, clinical, patent, and funding data, revealing hidden relationships and early signals of high-potential innovation.
We use algorithms optimized for the market intelligence or scouting use cases specifically for pharmaceutical and healthcare companies which maximizes the signal to noise ratio (and minimize hallucinations).
You can request a personalized demo with our team, where we’ll walk you through real use cases tailored to your industry, whether that’s scouting emerging startups, tracking new pharma technologies, or monitoring healthcare signals. This way, you see exactly how FounderNest fits your workflow.
“Pharmaceutical companies know that market research is critical - data that provides customer insights, competitive intelligence, behavioral tendencies, and product positioning.”
We live in a world where innovation has become almost synonymous with tech. Every headline, conference panel, and corporate strategy deck
Join companies like L'Oreal, Roche and Telefonica to supercharge your market intelligence and be one-step ahead of your competition.
FounderNest is an AI market intelligence platform that helps large corporations discover, analyze, and evaluate new markets, trends, and companies, making decisions faster and more strategic.
Product
By team
By industry
Resources
Why FounderNest
FounderNest © 2025, All rights reserved.
Book your personalized demo now.
Based on our customer satisfaction scores.
